Diagnostic and prognostic value of myocardial blood flow quantification as non-invasive indicator of cardiac allograft vasculopathy

European Heart Journal

Volumn 39, Issue 4, 2018, Pages 316-323

  Bravo, Paco E ^a   Bergmark, Brian A ^a   Vita, Tomas ^a   Taqueti, Viviany R ^a   Gupta, Ankur ^a   Seidelmann, Sara ^a   Christensen, Thomas E ^a   Osborne, Michael T ^a,b   Shah, Nishant R ^c   Ghosh, Nina ^d   Hainer, Jon ^a   Bibbo, Courtney F ^a   Harrington, Meagan ^a   Costantino, Fred ^a   Mehra, Mandeep R ^a   Dorbala, Sharmila ^a   Blankstein, Ron ^a   Desai, Akshay ^a   Stevenson, Lynne ^a   Givertz, Michael M ^a   Di Carli, Marcelo F ^a   more..

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c BROWN UNIVERSITY   (United States)

^d Ottawa Cardiovascular Centre   (Canada)

Author keywords

Cardiac allograft vasculopathy; Myocardial blood flow; PET

Indexed keywords

ACETYLSALICYLIC ACID; AMMONIA N 13; AZATHIOPRINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CYCLOSPORINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MYCOPHENOLIC ACID; PREDNISONE; RAPAMYCIN; TACROLIMUS;

ACUTE CORONARY SYNDROME; ADULT; ADVERSE OUTCOME; ARTICLE; CARDIAC ALLOGRAFT VASCULOPATHY; CARDIOVASCULAR MORTALITY; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ANGIOGRAPHY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; GOLD STANDARD; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LUNG TRANSPLANTATION; HEART MUSCLE BLOOD FLOW; HEART STRESS; HOSPITALIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL PERFUSION IMAGING; NON INVASIVE MEASUREMENT; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE DIAGNOSIS; RECEIVER OPERATING CHARACTERISTIC; RETRANSPLANTATION; RETROSPECTIVE STUDY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; ADVERSE EVENT; AGED; ALLOGRAFT; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; DIAGNOSTIC IMAGING; HEART TRANSPLANTATION; MIDDLE AGED; PATHOPHYSIOLOGY; PROCEDURES;

ADULT; AGED; ALLOGRAFTS; CORONARY ANGIOGRAPHY; CORONARY DISEASE; CORONARY VESSELS; FEMALE; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS;

EID: 85041234773     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehx683     Document Type: Article

References (10)

1. Lund LH, Edwards LB, Kucheryavaya AY, Benden C, Christie JD, Dipchand AI, Dobbels F, Goldfarb SB, Levvey BJ, Meiser B, Yusen RD, Stehlik J. The registry of the International Society for Heart and Lung Transplantation: thirty-first official adult heart transplant report-2014; focus theme: retransplantation. J Heart Lung Transplant 2014;33:996-1008.
2. Costanzo MR, Naftel DC, Pritzker MR, Heilman JK, 3rd, Boehmer JP, Brozena SC, Dec GW, Ventura HO, Kirklin JK, Bourge RC, Miller LW. Heart transplant coronary artery disease detected by coronary angiography: a multiinstitutional study of preoperative donor and recipient risk factors. Cardiac Transplant Research Database. J Heart Lung Transplant 1998;17:744-753.
3. Kindel SJ, Law YM, Chin C, Burch M, Kirklin JK, Naftel DC, Pruitt E, Carboni MP, Arens A, Atz AM, Dreyer WJ, Mahle WT, Pahl E. Improved detection of cardiac allograft vasculopathy: a multi-institutional analysis of functional parameters in pediatric heart transplant recipients. J Am Coll Cardiol 2015;66:547-557.
4. Mehra MR, Crespo-Leiro MG, Dipchand A, Ensminger SM, Hiemann NE, Kobashigawa JA, Madsen J, Parameshwar J, Starling RC, Uber PA. International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy. J Heart Lung Transplant 2010;29:717-727.
5. Wenning C, Stypmann J, Papavassilis P, Sindermann J, Schober O, Hoffmeier A, Scheld HH, Stegger L, Schafers M. Left ventricular dilation and functional impairment assessed by gated SPECT are indicators of cardiac allograft vasculopathy in heart transplant recipients. J Heart Lung Transplant 2012;31:719-728.
6. Chirakarnjanakorn S, Starling RC, Popovic ZB, Griffin BP, Desai MY. Dobutamine stress echocardiography during follow-up surveillance in heart transplant patients: diagnostic accuracy and predictors of outcomes. J Heart Lung Transplant 2015;34:710-717.
7. McArdle BA, Davies RA, Chen L, Small GR, Ruddy TD, Dwivedi G, Yam Y, Haddad H, Mielniczuk LM, Stadnick E, Hessian R, Guo A, Beanlands RS, de Kemp RA, Chow BJ. Prognostic value of rubidium-82 positron emission tomography in patients after heart transplant. Circ Cardiovasc Imaging 2014;7:930-937.
8. Prada-Delgado O, Estévez-Loureiro R, Paniagua-Martín MJ, López-Sainz A, Crespo-Leiro MG. Prevalence and prognostic value of cardiac allograft vasculopathy 1 year after heart transplantation according to the ISHLT recommended nomenclature. J Heart Lung Transplant 2012;31:332-333.
9. Arbustini E, Roberts WC. Morphological observations in the epicardial coronary arteries and their surroundings late after cardiac transplantation (allograft vascular disease). Am J Cardiol 1996;78:814-820.
10. Manrique A, Bernard M, Hitzel A, Bubenheim M, Tron C, Agostini D, Cribier A, Vera P, Bessou JP, Redonnet M. Diagnostic and prognostic value of myocardial perfusion gated SPECT in orthotopic heart transplant recipients. J Nucl Cardiol 2010;17:197-206.